Skip to content

Study · Not a test of the peptide alone · 2005

3 results

Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung.

Péqueux C, Breton C, Hagelstein MT, Geenen V, Legros JJ

Lung cancer (Amsterdam, Netherlands)25 Jul 2005Cited by 19 (Europe PMC)

PMID16043261 (opens in a new tab)DOI10.1016/j.lungcan.2005.05.027 (opens in a new tab)PepBankPUB-16043261
Source linkPubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneObservational studyOther

    In normal human lung, the oxytocin receptor (OTR) was colocalized with vascular endothelial cells and not expressed by epithelial lung cells.

    In plain wordsIn normal human lung tissue, the oxytocin receptor was found in blood vessel lining cells and not in epithelial lung cells.

    Peptide
    Oxytocin
    Outcome
    Not applicableOTR localization in normal human lung
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Respiratory

    Source sentences

    Summary
    Herein, we observe, in normal human lung, that OTR is colocalized with vascular endothelial cells of the lung and is not expressed by lung cells of epithelial nature.
    1 context sentence
    Summary · context
    This was addressed on normal human lung tissue, on SCLC and on non-SCLC (NSCLC).

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02HumanNot a test of Oxytocin aloneObservational studyOther

    In small-cell lung cancer biopsies, 86% expressed at least the oxytocin receptor.

    In plain wordsIn small-cell lung cancer samples, most (86%) carried the oxytocin receptor.

    Peptide
    Oxytocin
    Outcome
    Not applicableOTR expression in small-cell lung cancer biopsies
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Cancer

    Measurements

    Biopsies expressing OTR
    86%
    SCLC

    Source sentences

    Summary
    We observed that 86% of SCLC biopsies analyzed expressed at least the OTR and that 71% expressed the OTR, the V1aR and the V2R altogether.
    1 context sentence
    Summary · context
    This was addressed on normal human lung tissue, on SCLC and on non-SCLC (NSCLC).

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 03HumanNot a test of Oxytocin aloneObservational studyOther

    In non-small-cell lung cancer biopsies, 50% expressed at least the oxytocin receptor.

    In plain wordsIn non-small-cell lung cancer samples, half (50%) carried the oxytocin receptor.

    Peptide
    Oxytocin
    Outcome
    Not applicableOTR expression in non-small-cell lung cancer biopsies
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Cancer

    Measurements

    Biopsies expressing OTR
    50%
    NSCLC

    Source sentences

    Summary
    Comparatively, 50% of NSCLC biopsies tested expressed at least the OTR and 32% expressed the OTR, the V1aR and the V2R altogether.
    1 context sentence
    Summary · context
    This was addressed on normal human lung tissue, on SCLC and on non-SCLC (NSCLC).

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.